These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 9926529)

  • 1. Patterns of sexual and injecting risk behaviours in French intravenous drug users not reporting HIV and hepatitis C virus seropositivities.
    Vidal-Trécan G; Coste J; Varescon-Pousson I; Reboul-Marty J; Christoforov B; Boissonnas A
    Addiction; 1998 Nov; 93(11):1657-68. PubMed ID: 9926529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HCV status knowledge and risk behaviours amongst intravenous drug users.
    Vidal-Trécan G; Coste J; Varescon-Pousson I; Christoforov B; Boissonnas A
    Eur J Epidemiol; 2000 May; 16(5):439-45. PubMed ID: 10997831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relative risk of HIV among IDUs not in treatment in Malaysia.
    Vicknasingam B; Narayanan S; Navaratnam V
    AIDS Care; 2009 Aug; 21(8):984-91. PubMed ID: 20024754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Risk behaviors of intravenous drug users: are females taking more risks of HIV and HCV transmission?].
    Vidal-Trécan G; Coste J; Coeuret M; Delamare N; Varescon-Pousson I; Boissonnas A
    Rev Epidemiol Sante Publique; 1998 Jun; 46(3):193-204. PubMed ID: 9690286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methadone maintenance treatment and HIV risk-taking behaviour among injecting drug users in Berlin.
    Stark K; Müller R; Bienzle U; Guggenmoos-Holzmann I
    J Epidemiol Community Health; 1996 Oct; 50(5):534-7. PubMed ID: 8944860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV risk behaviours among injecting drug users in Northeast India following scale-up of a targeted HIV prevention programme.
    Armstrong G; Humtsoe C; Kermode M
    BMC Public Health; 2011 Dec; 11 Suppl 6(Suppl 6):S9. PubMed ID: 22375900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV prevalence and related risk behaviours among female partners of male injecting drugs users in Iran: results of a bio-behavioural survey, 2010.
    Alipour A; Haghdoost AA; Sajadi L; Zolala F
    Sex Transm Infect; 2013 Nov; 89 Suppl 3(Suppl 3):iii41-4. PubMed ID: 24064986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High HIV and hepatitis C prevalence amongst injecting drug users in Mauritius: findings from a population size estimation and respondent driven sampling survey.
    Johnston L; Saumtally A; Corceal S; Mahadoo I; Oodally F
    Int J Drug Policy; 2011 Jul; 22(4):252-8. PubMed ID: 21700442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with HIV testing among male injecting drug users: findings from a cross-sectional behavioural and biological survey in Manipur and Nagaland, India.
    Ganju D; Ramesh S; Saggurti N
    Harm Reduct J; 2016 Jun; 13(1):21. PubMed ID: 27324253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends and factors in human immunodeficiency virus and/or hepatitis C virus testing and infection among injection drug users newly entering methadone maintenance treatment in Guangdong Province, China 2006-2013: a consecutive cross sectional study.
    Liu Y; Liu Y; Zou X; Chen W; Ling L
    BMJ Open; 2017 Jul; 7(7):e015524. PubMed ID: 28710214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contraceptive practices of non-HIV-seropositive injecting drug users.
    Vidal-Trecan G; Warszawski J; Coste J; Bajos N; Delamare N; Grenier-Sennelier C; Boissonnas A
    Eur J Epidemiol; 2003; 18(9):863-9. PubMed ID: 14561045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C and HIV incidence and harm reduction program use in a conflict setting: an observational cohort of injecting drug users in Kabul, Afghanistan.
    Todd CS; Nasir A; Stanekzai MR; Fiekert K; Sipsma HL; Vlahov D; Strathdee SA
    Harm Reduct J; 2015 Oct; 12():22. PubMed ID: 26472126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Condom use among injection drug users accessing a supervised injecting facility.
    Marshall BD; Wood E; Zhang R; Tyndall MW; Montaner JS; Kerr T
    Sex Transm Infect; 2009 Apr; 85(2):121-6. PubMed ID: 18812391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding the association between injecting and sexual risk behaviors of injecting drug users in Manipur and Nagaland, India.
    Suohu K; Humtsoe C; Saggurti N; Sabarwal S; Mahapatra B; Kermode M
    Harm Reduct J; 2012 Dec; 9():40. PubMed ID: 23249619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of current HIV risk behaviour among injecting drug users in Warsaw, Poland.
    Stark K; Sieroslawski J; Müller R; Wirth D; Godwod-Sikorska C; Bienzle U
    Eur J Epidemiol; 1996 Jun; 12(3):315-7. PubMed ID: 8884201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
    Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
    MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for HIV-1 seropositivity in drug users under 30 years old in Haiphong, Vietnam.
    Nguyen TA; Hoang LT; Pham VQ; Detels R
    Addiction; 2001 Mar; 96(3):405-13. PubMed ID: 11255581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Condom use with primary partners among injecting drug users in Bangkok, Thailand and New York City, United States.
    Vanichseni S; Des Jarlais DC; Choopanya K; Friedmann P; Wenston J; Sonchai W; Sotheran JL; Raktham S; Carballo M; Friedman SR
    AIDS; 1993 Jun; 7(6):887-91. PubMed ID: 8363764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the determinants of safe injecting and condom use among injecting drug users.
    Myers T; Millson M; Rigby J; Ennis M; Rankin J; Mindell W; Strathdee S
    Addiction; 1995 Feb; 90(2):217-26. PubMed ID: 7703815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevalence of human immunodeficiency virus and risk behaviours among opioid users seen in an emergency room].
    Pérez González K; Domingo-Salvany A; Hartnoll R
    Gac Sanit; 1999; 13(1):7-15. PubMed ID: 10217672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.